down arrow

Medico Intercon.

  • Market Cap: Micro Cap
  • Industry: Finance/NBFC
  • ISIN: INE858Q01019
  • NSEID:
  • BSEID: 539938
INR
39.60
-0.8 (-1.98%)
BSENSE

Apr 11, 12:34 PM

BSE+NSE Vol: 400

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1000280,
    "name": "Medico Intercon.",
    "stock_name": "Medico Intercon.",
    "full_name": "Medico Intercontinental Ltd",
    "name_url": "stocks-analysis/medico-intercon",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "39.60",
    "chg": -0.8,
    "chgp": "-1.98%",
    "dir": -1,
    "prev_price": "40.40",
    "mcapval": "40.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 539938,
    "symbol": "",
    "ind_name": "Finance/NBFC",
    "ind_code": 5,
    "isin": "INE858Q01019",
    "curr_date": "Apr 11, 12:34 PM",
    "curr_time": "00:09 AM",
    "bse_nse_vol": "400 ",
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/medico-intercon-1000280-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Medico Intercontinental Faces Significant Volatility Amid Broader Market Caution",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medico-intercontinental-hits-52-week-low-amid-six-day-decline-in-stock-price-1645242",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/MedicoIntercont_priceRelatedfactors_842659.png",
        "date": "2025-03-28 14:07:05",
        "description": "Medico Intercontinental, a microcap in the finance and NBFC sector, has faced notable volatility, reaching a new 52-week low. The stock has declined for six consecutive days, with a one-year performance of -7.88%. Despite a rise in profits, revenue challenges and bearish technical indicators persist amid cautious market sentiment."
      },
      {
        "title": "Medico Intercontinental Faces Flat Sales Amid Weak Long-Term Fundamentals and Bearish Market Indicators",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/medico-intercontinental-downgraded-to-strong-sell-amid-declining-financial-performance-1047294",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/MedicoIntercont_mojoScore_463091.png",
        "date": "2025-02-18 18:39:09",
        "description": "Medico Intercontinental, a microcap in the finance/NBFC sector, has experienced a recent evaluation adjustment amid flat financial performance for the quarter ending December 2024. Despite a decline in net sales, the company shows a 25.5% profit increase over the past year, indicating some resilience in a challenging market."
      },
      {
        "title": "Medico Intercontinental Faces Significant Volatility Amidst Sector Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medico-intercontinental-hits-52-week-low-amid-ongoing-decline-and-volatility-1040124",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/MedicoIntercont_priceRelatedfactors_451083.png",
        "date": "2025-02-17 09:40:57",
        "description": "Medico Intercontinental, a microcap in the finance and NBFC sector, has hit a new 52-week low amid significant volatility, trailing its sector. The stock has declined 12.92% over three days and is trading below key moving averages, reflecting ongoing challenges in a competitive financial landscape."
      },
      {
        "title": "Medico Intercontinental Reports Stable Financial Results Amid Significant Score Adjustment in February 2025",
        "link": "https://www.marketsmojo.com/news/result-analysis/medico-intercontinental-reports-flat-financial-performance-for-december-2024-results-1013457",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/MedicoIntercont_quaterlyResult_450275.png",
        "date": "2025-02-14 15:36:15",
        "description": "Medico Intercontinental has announced its financial results for the quarter ending December 2024, revealing stable performance. However, the company's evaluation score has significantly decreased over the past three months, indicating evolving dynamics in its financial landscape that may require closer analysis by stakeholders in the finance/NBFC sector."
      },
      {
        "title": "Medico Intercontinental Hits 52-Week Low Amid Broader Market Challenges in October 2023",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medico-intercontinental-hits-52-week-low-of-rs-37-3-amid-ongoing-decline-1012281",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/MedicoIntercont_priceRelatedfactors_449584.png",
        "date": "2025-02-14 13:36:11",
        "description": "Medico Intercontinental, a microcap in the Finance/NBFC sector, reached a new 52-week low today, continuing a downward trend with a 53.72% decline over the past year. Despite outperforming its sector slightly, the stock remains below key moving averages, indicating ongoing challenges in the market."
      }
    ],
    "total": 33,
    "sid": "1000280",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/medico-intercontinental-1000280"
  },
  "announcements": [
    {
      "caption": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A",
      "datetime": "08-Apr-2025",
      "details": "<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Medico Intercontinental Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24100GJ1984PLC111413</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>14.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: PUNEETA SHARMA <br/> Designation: COMPANY SECRETARY AND COMPLIANCE OFFICER <br/> EmailId: mail@medicointercontinental.com</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: JAY SHARADKUMAR SHAH <br/> Designation: CHIEF FINANCIAL OFFICER <br/> EmailId: mail@medicointercontinental.cm</div> </div> <div> <br/> Date: 08/04/2025<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for In Compliances Of Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015",
      "datetime": "07-Apr-2025",
      "details": "Outcome of Board meeting",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "07-Apr-2025",
      "details": "Confirmation Certificate under Reg. 74(5) of SEBI (DP) Regulations 2018.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Medico Intercontinental Ltd has declared <strong>1%</strong> dividend, ex-date: 23 Jun 23",
          "dt": "2023-06-23",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

08-Apr-2025 | Source : BSE

Format of Initial Disclosure to be made by an entity identified as a Large Corporate.

Sr. No. Particulars Details
1Name of CompanyMedico Intercontinental Ltd
2CIN NO.L24100GJ1984PLC111413
3 Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr) 14.00
4Highest Credit Rating during the previous FY NA
4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable
5Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the frameworkBSE


We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No



Name of the Company Secretary: PUNEETA SHARMA
Designation: COMPANY SECRETARY AND COMPLIANCE OFFICER
EmailId: mail@medicointercontinental.com
Name of the Chief Financial Officer: JAY SHARADKUMAR SHAH
Designation: CHIEF FINANCIAL OFFICER
EmailId: mail@medicointercontinental.cm

Date: 08/04/2025

Note: In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

Board Meeting Outcome for In Compliances Of Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015

07-Apr-2025 | Source : BSE

Outcome of Board meeting

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

07-Apr-2025 | Source : BSE

Confirmation Certificate under Reg. 74(5) of SEBI (DP) Regulations 2018.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Medico Intercontinental Ltd has declared 1% dividend, ex-date: 23 Jun 23

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available